Restricted access

Research article

First published online June, 2001

An Open-Label,Phase I,Dose-Escalation Study of Tumor Necrosis Factor-α (TNFerade™ Biologic) Gene Transfer with Radiation Therapy for Locally Advanced,Recurrent,or Metastatic Solid Tumors